TY  - GEN
AU  - Fuke,Toshiya
AU  - Abe,Yoshifusa
AU  - Hibino,Satoshi
AU  - Takeshi,Mikawa
AU  - Saito,Takako
AU  - Sakurai,Shunsuke
AU  - Watanabe,Shuichiro
AU  - Murayama,Jun-ichiro
AU  - Itabashi,Kazuo
AU  - Nakano,Yasuko
TI  - Mizoribine requires individual dosing due to variation of bioavailability
SN  - 1442-200X
PY  - 2013///1126
KW  - Adolescent
KW  - Biological Availability
KW  - Child
KW  - Child, Preschool
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunosuppressive Agents
KW  - administration & dosage
KW  - Lupus Nephritis
KW  - blood
KW  - Male
KW  - Retrospective Studies
KW  - Ribonucleosides
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1442-200X.2012.03733.x
ER  -